What Is Electroconvulsive Therapy (ECT)? Electroconvulsive therapy (ECT) is one of the safest and most effective treatments available for depression and bipolar disorder. Electrodes are placed on your ...
The most prominent barriers to expanding an existing ECT service were lack of physical space, stigma on the part of patients, and transportation difficulties. The most prominent barriers to initiating ...
Electroshock therapy, also known as electroconvulsive therapy (ECT), is a treatment for severe major depression, bipolar depression, and other mental health conditions. Psychiatrists may recommend ECT ...
Electroconvulsive therapy is a safe, controlled procedure for depression and other psychological disorders that have not responded to other treatments. A small amount of electric current is passed ...
ECT response–guided sequential strategy. This strategy comprises two phases. In the initial phase, the goal is to exploit the advantage of ECT in rapidly inducing mood improvement and then to ...
High rates of early relapse following electroconvulsive therapy (ECT) are typically reported in the literature. Current treatment guidelines offer little information to clinicians on the optimal ...
The Showtime drama "Yellowjackets" has repeatedly received praise for its portrayal of trauma, but a recent episode in particular has people buzzing. In it, we see that Simone Kessell's Lottie was so ...
Five co-researchers and I have just launched the first-ever international survey of people who have received electroconvulsive therapy (ECT), called electroshock therapy in the United States. The ...
Sameer Jauhar receives funding from the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King’s College ...
Electroconvulsive Therapy (ECT) remains a highly controversial treatment. It involves administering an electric shock to the brain to induce a seizure, with the intention of alleviating mental health ...
Sydney E. Smith does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...